“…FN is a secreted matrix protein whose production is potently increased upon induction of EMT [32,33]. Furthermore, FN dramatically augments the secretion of MMP-9 through the MEK1/ERK and the PI-3K/Akt-dependent pathways in breast and ovarian cancer cells, thereby triggering metastasis of tumor cells [8,34]. Consistent with these reports, our results showed that the adhesion and invasion of breast cancer cells increased significantly in response to rhFN treatment.…”